September 14, 2026
See how CellCarta's California laboratory takes early-stage biomarker programs from concept to validated assay in under three months, with specialized ADC biomarker profiling services, a vast assay library, and an in-house biobank available to accelerate program timelines. Read on to see why Lake Forest is where fast-moving programs start, and how they scale globally from there.
September 14, 2026
See how CellCarta's California laboratory takes early-stage biomarker programs from concept to validated assay in under three months, with specialized ADC biomarker profiling services, a vast assay library, and an in-house biobank available to accelerate program timelines. Read on to see why Lake Forest is where fast-moving programs start, and how they scale globally from there.
September 14, 2026
CellCarta is a global CRO that brings genomics, histopathology, immunology, and proteomics together, giving you the scientific depth, operational scale, and hands-on partnership your program deserves from discovery through phase III trials and CDx.
In this brochure, learn more about CellCarta's biomarker capabilities, logistics support, regulatory infrastructure, and scientific expertise built to support your program through every phase of development, including CDx.
September 14, 2026
CellCarta is a global CRO that brings genomics, histopathology, immunology, and proteomics together, giving you the scientific depth, operational scale, and hands-on partnership your program deserves from discovery through phase III trials and CDx.
In this brochure, learn more about CellCarta's biomarker capabilities, logistics support, regulatory infrastructure, and scientific expertise built to support your program through every phase of development, including CDx.
August 17, 2026
CellCarta offers a full range of validated genomic assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with several commercial assays. Contact us for any custom development.
August 17, 2026
CellCarta offers a full range of validated genomic assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with several commercial assays. Contact us for any custom development.
August 10, 2026
CellCarta offers a full range of validated human IHC, multiplex IHC (mIHC) and multiplex immunofluorescence (mIF) assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with hundreds more than represented in the brochure.
Contact us for any custom development!
August 10, 2026
CellCarta offers a full range of validated human IHC, multiplex IHC (mIHC) and multiplex immunofluorescence (mIF) assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with hundreds more than represented in the brochure.
Contact us for any custom development!
May 25, 2026
May 25, 2026
